According to the 2018 ASCO-CAP guidelines for HER2 testing in breast cancer, HER2-low expression breast cancer is characterized by a HER2 IHC score of 1 + or 2 + along with a negative ISH test result [5]. The gene discussed is ERBB2; the disease is breast carcinoma.